STSA insider filings

Satsuma Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-12. Screen STSA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for STSA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Satsuma Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2023-06-124RA CAPITAL MANAGEMENT, L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Code (U): 5,914,252 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084Riebe Michael T — DirectorDisposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 14,893 (derivative) @ $0 · Disposition to issuer (D): 12,765 (derivative) @ $0 · Disposition to issuer (D): 12,765 (derivative)EDGAR
2023-06-084Harsch Mutya — DirectorDisposition to issuer (D): 40,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084Shin Nippon Biomedical Laboratories, Ltd. — 10% ownerPurchase (P): 22,053,581 @ $0.91 · Purchase (P): 8,423,732 @ $0.91EDGAR
2023-06-084TAKANASHI KEN — Director, 10% ownerPurchase (P): 22,053,581 @ $0.91 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084O'Neil Thomas P. — Chief Financial OfficerCode (U): 13,877 @ $0.91 · Disposition to issuer (D): 60,000 (derivative) @ $0 · Disposition to issuer (D): 80,000 (derivative) @ $0 · Disposition to issuer (D): 190,000 (derivative) @ $0 · Disposition to issuer (D): 72,340 (derivative) @ $0 · Disposition to issuer (D): 76,595 (derivative) @ $0EDGAR
2023-06-084Sandoval Elisabeth — DirectorDisposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 14,893 (derivative) @ $0EDGAR
2023-06-084Shah Rajeev M. — Director, 10% ownerCode (U): 5,914,252 @ $0.91 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084Lukatch Heath — DirectorDisposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084Soloway Thomas P — DirectorDisposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2023-06-084Kollins John A — President and CEO, DirectorCode (U): 305,911 @ $0.91 · Disposition to issuer (D): 175,000 (derivative) @ $0 · Disposition to issuer (D): 240,000 (derivative) @ $0 · Disposition to issuer (D): 505,000 (derivative) @ $0 · Disposition to issuer (D): 276,595 (derivative) @ $0 · Disposition to issuer (D): 127,659 (derivative) @ $0 · +2 moreEDGAR
2023-06-084KING THOMAS BRAXTON — DirectorDisposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 14,893 (derivative) @ $0 · Disposition to issuer (D): 12,765 (derivative) @ $0 · Disposition to issuer (D): 12,765 (derivative)EDGAR
2022-12-094/ATAKANASHI KEN — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-11-234Leonard Braden Michael — 10% ownerPurchase (P): 150,000 @ $0.71EDGAR
2022-11-164COMMODORE CAPITAL LP — 10% ownerSale (S): 3,250,000 @ $0.71EDGAR
2022-11-164Leonard Braden Michael — 10% ownerPurchase (P): 5,608,306 @ $0.69 · Purchase (P): 531,000 @ $0.63 · Purchase (P): 300,694 @ $0.63EDGAR
2022-06-074Harsch Mutya — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074Riebe Michael T — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074TAKANASHI KEN — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074O'Neil Thomas P. — Chief Financial OfficerGrant/award (A): 190,000 (derivative) @ $0EDGAR
2022-06-074Sandoval Elisabeth — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074Lukatch Heath — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074Soloway Thomas P — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074Kollins John A — President and CEO, DirectorGrant/award (A): 505,000 (derivative) @ $0EDGAR
2022-06-074RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-074ALBRECHT DETLEF — Chief Medical OfficerGrant/award (A): 190,000 (derivative) @ $0EDGAR
2022-06-074KING THOMAS BRAXTON — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-11-294COMMODORE CAPITAL LP — 10% ownerPurchase (P): 2,922 @ $5.42EDGAR
2021-11-234COMMODORE CAPITAL LP — 10% ownerPurchase (P): 3,225 @ $5.44 · Purchase (P): 9,979 @ $5.49EDGAR
2021-11-124COMMODORE CAPITAL LP — 10% ownerPurchase (P): 9,622 @ $5.85 · Purchase (P): 7,941 @ $6.05EDGAR
2021-11-104COMMODORE CAPITAL LP — 10% ownerPurchase (P): 560 @ $5.99EDGAR
2021-11-084COMMODORE CAPITAL LP — 10% ownerPurchase (P): 1,400 @ $5.88 · Purchase (P): 7,800 @ $5.95EDGAR
2021-11-044COMMODORE CAPITAL LP — 10% ownerPurchase (P): 8,880 @ $5.64EDGAR
2021-11-024COMMODORE CAPITAL LP — 10% ownerPurchase (P): 44,651 @ $5.71EDGAR
2021-10-294COMMODORE CAPITAL LP — 10% ownerPurchase (P): 39,581 @ $5.45 · Purchase (P): 15,082 @ $5.55EDGAR
2021-10-254COMMODORE CAPITAL LP — 10% ownerPurchase (P): 32,816 @ $5.40 · Purchase (P): 27,629 @ $5.51EDGAR
2021-10-214COMMODORE CAPITAL LP — 10% ownerPurchase (P): 87,580 @ $5.07 · Purchase (P): 40,663 @ $5.44EDGAR
2021-10-194COMMODORE CAPITAL LP — 10% ownerPurchase (P): 126,000 @ $4.83 · Purchase (P): 36,194 @ $4.87EDGAR
2021-10-124Harsch Mutya — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-04-054RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner
Other (J): 566,011 @ $5.91 · Other (J): 192,387 @ $5.91EDGAR
2021-03-024RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 1,232,394 @ $5.68EDGAR
2020-12-074O'Neil Thomas P. — Chief Financial OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2020-12-074Sandoval Elisabeth — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-074Shah Rajeev M. — Director, 10% ownerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-074Lukatch Heath — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-074Soloway Thomas P — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-074Kollins John A — President and CEO, DirectorGrant/award (A): 240,000 (derivative) @ $0EDGAR
2020-12-074RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Grant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-074ALBRECHT DETLEF — Chief Medical OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2020-12-074KING THOMAS BRAXTON — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Satsuma Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-06-088-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-038-K8.01 — Other EventsEDGAR
2023-04-178-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-168-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=STSA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs